HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027

项目总结 开普敦大学临床试验中心(UCTU)的总部设在#年的Desmond Tutu艾滋病毒中心 南非开普敦。CTU的主要目标是提供高效、有效和集成的 临床试验股，为全球艾滋病毒和结核病流行控制作出贡献。UCTU已经 提供艾滋病毒、结核病和性传播感染方面的世界标准临床试验的能力、能力和能力 在广泛的人群中进行治疗和预防。 UCTU的核心优势之一是其在南部非洲的位置。最近的报告估计， 在全球3690万艾滋病毒携带者中，2570万人生活在撒哈拉以南非洲。因此，该小组- 非洲大陆在提供治疗和预防方法方面面临重大挑战，但也面临着 为创新进步作出重大贡献。除了它的关键位置，UCTU 提供世界级的科学领导、行政支持和公共基础设施。这将使 六个久负盛名的、多样化的临床研究网站将为本组织的研究议程做出一致贡献 四个由NIH资助的网络。每个临床研究地点都位于开普敦周围的社区 那里艾滋病毒、结核病和其他疾病的负担很高。因此，美国国立卫生研究院的研究议程是 在最需要治疗和预防的社区得到落实。 总部设在开普敦大学的这个CTU由一个机构提供容纳和支持 一直被评为非洲最好的大学，最近有一所健康科学学院位居榜首 全球范围内为100。所有临床研究站点都可以使用高质量的实验室，可以说是最好的 科学专业知识和该国最好的医疗诊断和调查资源。该财团 的临床研究站点都是开普敦大学的所有组件和附属机构，因此共享 相同或类似的管理平台，支持和放大效率和协同效应。

PROJECT SUMMARY The University of Cape Town Clinical Trials Unit (UCTCTU) is based at the Desmond Tutu HIV Centre in Cape Town, South Africa. The CTU’s primary goal is to provide a highly efficient, effective, and integrated Clinical Trials Unit that contributes to the global epidemic control of HIV and Tuberculosis. The UCTCTU has the capacity, capability and competence to deliver world standard clinical trials in HIV, tuberculosis, and STI treatment and prevention in a broad range of populations. One of the core advantages of the UCTCTU is its location in Southern Africa. Recent reports estimate that of the 36.9 million people living with HIV globally, 25.7 million are living in sub-Saharan Africa. Thus, the sub- continent faces significant challenges in delivering treatments and methods of prevention but also stands to make a significant contribution to innovation and progress. In addition to its key location, the UCTCTU provides world-class scientific leadership, administrative support, and common infrastructure. This enables six well-established, diverse Clinical Research Sites to contribute cohesively to the research agenda of the four NIH funded networks. Each of the Clinical Research Sites are located in communities around Cape Town where the burden of HIV, tuberculosis and other diseases is high. Thus, the research agenda of the NIH is being fulfilled in communities where treatment and prevention is needed most. Based at the University of Cape Town, this CTU is accommodated and supported by an institution that is consistently ranked the best university in Africa, with a Health Science Faculty recently ranked in the Top 100 globally. All Clinical Research Sites have access to high-quality laboratories, with arguably the finest scientific expertise and best medical diagnostic and investigative resources in the country. The consortium of Clinical Research Sites are all components and affiliates of the University of Cape Town and thus share the same or similar management platforms, supporting and amplifying efficiencies and synergies.